Cargando…

Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community

BACKGROUND: Insulin resistance carries increased risk of heart failure, although the pathophysiological mechanisms remain unclear. LV global longitudinal strain (LVGLS) assessed by speckle-tracking echocardiography has emerged as an important tool to detect early LV systolic abnormalities. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirose, Kazutoshi, Nakanishi, Koki, Daimon, Masao, Sawada, Naoko, Yoshida, Yuriko, Iwama, Kentaro, Yamamoto, Yuko, Ishiwata, Jumpei, Hirokawa, Megumi, Koyama, Katsuhiro, Nakao, Tomoko, Morita, Hiroyuki, Di Tullio, Marco R., Homma, Shunichi, Komuro, Issei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818760/
https://www.ncbi.nlm.nih.gov/pubmed/33478525
http://dx.doi.org/10.1186/s12933-020-01201-6
_version_ 1783638906864926720
author Hirose, Kazutoshi
Nakanishi, Koki
Daimon, Masao
Sawada, Naoko
Yoshida, Yuriko
Iwama, Kentaro
Yamamoto, Yuko
Ishiwata, Jumpei
Hirokawa, Megumi
Koyama, Katsuhiro
Nakao, Tomoko
Morita, Hiroyuki
Di Tullio, Marco R.
Homma, Shunichi
Komuro, Issei
author_facet Hirose, Kazutoshi
Nakanishi, Koki
Daimon, Masao
Sawada, Naoko
Yoshida, Yuriko
Iwama, Kentaro
Yamamoto, Yuko
Ishiwata, Jumpei
Hirokawa, Megumi
Koyama, Katsuhiro
Nakao, Tomoko
Morita, Hiroyuki
Di Tullio, Marco R.
Homma, Shunichi
Komuro, Issei
author_sort Hirose, Kazutoshi
collection PubMed
description BACKGROUND: Insulin resistance carries increased risk of heart failure, although the pathophysiological mechanisms remain unclear. LV global longitudinal strain (LVGLS) assessed by speckle-tracking echocardiography has emerged as an important tool to detect early LV systolic abnormalities. This study aimed to investigate the association between insulin resistance and subclinical left ventricular (LV) dysfunction in a sample of the general population without overt cardiac disease. METHODS: We investigated 539 participants who voluntarily underwent extensive cardiovascular health check including laboratory test and speckle-tracking echocardiography. Glycemic profiles were categorized into 3 groups according to homeostatic model assessment of insulin resistance (HOMA-IR): absence of insulin resistance (HOMA-IR < 1.5), presence of insulin resistance (HOMA-IR ≥ 1.5) and diabetes mellitus (DM). Multivariable logistic regression models were conducted to evaluate the association between abnormal glucose metabolism and impaired LVGLS (> − 16.65%). RESULTS: Forty-five (8.3%) participants had DM and 66 (12.2%) had abnormal HOMA-IR. LV mass index and E/e′ ratio did not differ between participants with and without abnormal HOMA-IR, whereas abnormal HOMA-IR group had significantly decreased LVGLS (− 17.6 ± 2.6% vs. − 19.7 ± 3.1%, p < 0.05). The prevalence of impaired LVGLS was higher in abnormal HOMA-IR group compared with normal HOMA-IR group (42.4% vs. 14.0%) and similar to that of DM (48.9%). In multivariable analyses, glycemic abnormalities were significantly associated with impaired LVGLS, independent of traditional cardiovascular risk factors and pertinent laboratory and echocardiographic parameters [adjusted odds ratio (OR) 2.38, p = 0.007 for abnormal HOMA-IR; adjusted OR 3.02, p = 0.003 for DM]. The independent association persisted even after adjustment for waist circumference as a marker of abdominal adiposity. Sub-group analyses stratified by body mass index showed significant association between abnormal HOMA-IR and impaired LVGLS in normal weight individuals (adjusted OR 4.59, p = 0.001), but not in overweight/obese individuals (adjusted OR 1.62, p = 0.300). CONCLUSIONS: In the general population without overt cardiac disease, insulin resistance carries independent risk for subclinical LV dysfunction, especially in normal weight individuals.
format Online
Article
Text
id pubmed-7818760
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78187602021-01-22 Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community Hirose, Kazutoshi Nakanishi, Koki Daimon, Masao Sawada, Naoko Yoshida, Yuriko Iwama, Kentaro Yamamoto, Yuko Ishiwata, Jumpei Hirokawa, Megumi Koyama, Katsuhiro Nakao, Tomoko Morita, Hiroyuki Di Tullio, Marco R. Homma, Shunichi Komuro, Issei Cardiovasc Diabetol Original Investigation BACKGROUND: Insulin resistance carries increased risk of heart failure, although the pathophysiological mechanisms remain unclear. LV global longitudinal strain (LVGLS) assessed by speckle-tracking echocardiography has emerged as an important tool to detect early LV systolic abnormalities. This study aimed to investigate the association between insulin resistance and subclinical left ventricular (LV) dysfunction in a sample of the general population without overt cardiac disease. METHODS: We investigated 539 participants who voluntarily underwent extensive cardiovascular health check including laboratory test and speckle-tracking echocardiography. Glycemic profiles were categorized into 3 groups according to homeostatic model assessment of insulin resistance (HOMA-IR): absence of insulin resistance (HOMA-IR < 1.5), presence of insulin resistance (HOMA-IR ≥ 1.5) and diabetes mellitus (DM). Multivariable logistic regression models were conducted to evaluate the association between abnormal glucose metabolism and impaired LVGLS (> − 16.65%). RESULTS: Forty-five (8.3%) participants had DM and 66 (12.2%) had abnormal HOMA-IR. LV mass index and E/e′ ratio did not differ between participants with and without abnormal HOMA-IR, whereas abnormal HOMA-IR group had significantly decreased LVGLS (− 17.6 ± 2.6% vs. − 19.7 ± 3.1%, p < 0.05). The prevalence of impaired LVGLS was higher in abnormal HOMA-IR group compared with normal HOMA-IR group (42.4% vs. 14.0%) and similar to that of DM (48.9%). In multivariable analyses, glycemic abnormalities were significantly associated with impaired LVGLS, independent of traditional cardiovascular risk factors and pertinent laboratory and echocardiographic parameters [adjusted odds ratio (OR) 2.38, p = 0.007 for abnormal HOMA-IR; adjusted OR 3.02, p = 0.003 for DM]. The independent association persisted even after adjustment for waist circumference as a marker of abdominal adiposity. Sub-group analyses stratified by body mass index showed significant association between abnormal HOMA-IR and impaired LVGLS in normal weight individuals (adjusted OR 4.59, p = 0.001), but not in overweight/obese individuals (adjusted OR 1.62, p = 0.300). CONCLUSIONS: In the general population without overt cardiac disease, insulin resistance carries independent risk for subclinical LV dysfunction, especially in normal weight individuals. BioMed Central 2021-01-21 /pmc/articles/PMC7818760/ /pubmed/33478525 http://dx.doi.org/10.1186/s12933-020-01201-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Investigation
Hirose, Kazutoshi
Nakanishi, Koki
Daimon, Masao
Sawada, Naoko
Yoshida, Yuriko
Iwama, Kentaro
Yamamoto, Yuko
Ishiwata, Jumpei
Hirokawa, Megumi
Koyama, Katsuhiro
Nakao, Tomoko
Morita, Hiroyuki
Di Tullio, Marco R.
Homma, Shunichi
Komuro, Issei
Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community
title Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community
title_full Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community
title_fullStr Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community
title_full_unstemmed Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community
title_short Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community
title_sort impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818760/
https://www.ncbi.nlm.nih.gov/pubmed/33478525
http://dx.doi.org/10.1186/s12933-020-01201-6
work_keys_str_mv AT hirosekazutoshi impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT nakanishikoki impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT daimonmasao impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT sawadanaoko impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT yoshidayuriko impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT iwamakentaro impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT yamamotoyuko impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT ishiwatajumpei impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT hirokawamegumi impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT koyamakatsuhiro impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT nakaotomoko impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT moritahiroyuki impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT ditulliomarcor impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT hommashunichi impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity
AT komuroissei impactofinsulinresistanceonsubclinicalleftventriculardysfunctioninnormalweightandoverweightobesejapanesesubjectsinageneralcommunity